The MAP kinase protein family has a critical role in cellular signaling events, with MAP kinase p38α acting in inflammatory processes and being an important drug discovery target. MAP kinase drug design efforts have focused on small molecule inhibitors of the ATP catalytic site, which exhibit dose-limiting adverse effects. Therefore, characterizing other potential sites that bind substrates, inhibitors or allosteric effectors is of great interest. Here, we present the crystal structure of p38α MAP kinase, which has a lead compound bound in both the active site and in the lipid-binding site of the C-terminal cap. This C-terminal cap is formed from an extension to the kinase fold, unique to the MAP kinase and CDK families, and GSK-3 kinase. Binding of this lead, 4-[3-(4-fluorophenyl)-1H-pyrazol-4-yl]pyridine, to wild-type p38α induces movement of the C-terminal cap region, creating a hydrophobic pocket centered around residue Trp197. Computational analysis of this C-Terminal domain pocket indicates notable flexibility for potentially binding different shaped compounds, including lipids, oxidized arachidonic acid species such as leukotrienes and small molecule effectors. Furthermore, our structural results defining the open p38α C-lobe pocket provide a detailed framework for the design of novel small molecules with affinities comparable to active site binders: to bind and potentially modulate the shape and activity of p38α in predetermined ways. Moreover, these results and analyses of p38α suggest strategies for designing specific binding compounds applicable to other MAP kinases, as well as the CDK kinase family and GSK-3β that also utilize the C-terminal insert in their interactions.
Keywordsp38α; MAP Kinase Insert; small molecule inhibitor; leukotriene; anisomycin Protein kinases have critical functions in cellular signaling cascades and their dysregulation is linked to human diseases, including cancer, diabetes, neurodegeneration and inflammatorybased disorders. Concerted characterization of protein kinases is being conducted to define © 2009 Elsevier Ltd. All rights reserved. *Correspondence sent to John A. Tainer, jat@scripps.edu, Tel: (858) Fax: (858) 784-2277. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Protein Data Bank accession codeStructure factors and coordinates for the p38α:4-FPP complex have been deposited in the RCSB Protein Data Bank, with the accession code 2P5A.
NIH Public Access
NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript their molecular mechanisms of action, and for drug design efforts. One group of kinases...